Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on HCP

Related HCP
Top Performing Industries For July 10, 2014
Updated Research Report on HCP - Analyst Blog

In a report published Friday, Jefferies & Company reiterated its Hold rating on HCP (NYSE: HCP), and slightly raised its price target from $45.00 to $46.00.

Jefferies noted, “We are updating our estimates for HCP and AMRE following announcements during the NAREIT conference in San Diego, CA. Our price target for HCP also increases to $46 from $45. See our accompanying note entitled ‘Tweets from NAREIT (November 2012 Edition)'.”

HCP closed on Thursday at $43.78.

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (HCP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free